Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barchiesi

Showing results (101-110 of 353) with videos related to

Pageof 36
Sort By:
Diseases (Basel, Switzerland)|October 28, 2025
Severe Acute SARS-CoV-2 Infection and Long COVID: What Do We Know So Far? New Challenges in Diagnosis and ManagementSara Mazzanti, Francesco Barchiesi, Francesco Pallotta, et al.
Mycopathologia|June 24, 2010
Disruption of homocitrate synthase genes in Candida albicans affects growth but not virulenceKrzysztof Kur, Iwona Gabriel, Joachim Morschhäuser, et al.
BMC Infectious Diseases|August 11, 2016
Factors related to outcome of bloodstream infections due to Candida parapsilosis complexFrancesco Barchiesi, Elena Orsetti, Patrizia Osimani, et al.
Mycoses|February 20, 2007
Voriconazole and multidrug resistance in Candida albicansRoland Wakieć, Rajendra Prasad, Joachim Morschhäuser, et al.
Diagnostic Microbiology and Infectious Disease|November 16, 2004
Tolerance to amphotericin B in clinical isolates of Candida tropicalisFrancesco Barchiesi, Monia Maracci, Isabella Baldassarri, et al.
Minerva Ginecologica|March 1, 1992
[The breast in adolescence. Physiopathological and clinical considerations]S Barchiesi, C De Felice, M P Nusiner, et al.
Peptides|December 28, 1999
Antimicrobial activity of polycationic peptidesA Giacometti, O Cirioni, F Barchiesi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 26, 2000
Efficacy of treatment with paromomycin, azithromycin, and nitazoxanide in a patient with disseminated cryptosporidiosisA Giacometti, F Burzacchini, O Cirioni, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2000
Short-term exposure to membrane-active antibiotics inhibits Cryptosporidium parvum infection in cell cultureA Giacometti, O Cirioni, M S Del Prete, et al.
Scandinavian Journal of Infectious Diseases|September 23, 2014
Comparison of liver fibrosis progression in HIV/HCV co-infected and HCV mono-infected patients by transient elastometrySusanna Mazzocato, Elena Orsetti, Rosaria Gesuita, et al.
Pageof 36

Showing results (101-110 of 353) with videos related to

Sort By:
Pageof 36
Diseases (Basel, Switzerland)|October 28, 2025
Severe Acute SARS-CoV-2 Infection and Long COVID: What Do We Know So Far? New Challenges in Diagnosis and ManagementSara Mazzanti, Francesco Barchiesi, Francesco Pallotta, et al.
Mycopathologia|June 24, 2010
Disruption of homocitrate synthase genes in Candida albicans affects growth but not virulenceKrzysztof Kur, Iwona Gabriel, Joachim Morschhäuser, et al.
BMC Infectious Diseases|August 11, 2016
Factors related to outcome of bloodstream infections due to Candida parapsilosis complexFrancesco Barchiesi, Elena Orsetti, Patrizia Osimani, et al.
Mycoses|February 20, 2007
Voriconazole and multidrug resistance in Candida albicansRoland Wakieć, Rajendra Prasad, Joachim Morschhäuser, et al.
Diagnostic Microbiology and Infectious Disease|November 16, 2004
Tolerance to amphotericin B in clinical isolates of Candida tropicalisFrancesco Barchiesi, Monia Maracci, Isabella Baldassarri, et al.
Minerva Ginecologica|March 1, 1992
[The breast in adolescence. Physiopathological and clinical considerations]S Barchiesi, C De Felice, M P Nusiner, et al.
Peptides|December 28, 1999
Antimicrobial activity of polycationic peptidesA Giacometti, O Cirioni, F Barchiesi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 26, 2000
Efficacy of treatment with paromomycin, azithromycin, and nitazoxanide in a patient with disseminated cryptosporidiosisA Giacometti, F Burzacchini, O Cirioni, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2000
Short-term exposure to membrane-active antibiotics inhibits Cryptosporidium parvum infection in cell cultureA Giacometti, O Cirioni, M S Del Prete, et al.
Scandinavian Journal of Infectious Diseases|September 23, 2014
Comparison of liver fibrosis progression in HIV/HCV co-infected and HCV mono-infected patients by transient elastometrySusanna Mazzocato, Elena Orsetti, Rosaria Gesuita, et al.
Pageof 36